5mC and H3K9me3 of TRAF3IP2 promoter region accelerates the progression of translocation renal cell carcinoma
Abstract Background In our previous study, we found that lncRNA TRAF3IP2 antisense RNA 1 (TRAF3IP2-AS1) could play a critical role in the progression of NONO-TFE3 translocation renal cell carcinoma (NONO-TFE3 tRCC). However, the function of TRAF3IP2 (TRAF3 interacting protein 2), encoded by the comp...
Main Authors: | Lei Yang, Yi Chen, Ning Liu, Yanwen Lu, Xin Li, Wenliang Ma, Weidong Gan, Dongmei Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-07-01
|
Series: | Biomarker Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40364-022-00402-3 |
Similar Items
-
Low expression of TRAF3IP2-AS1 promotes progression of NONO-TFE3 translocation renal cell carcinoma by stimulating N 6-methyladenosine of PARP1 mRNA and downregulating PTEN
by: Lei Yang, et al.
Published: (2021-03-01) -
Targeting TRAF3IP2 inhibits angiogenesis in glioblastoma
by: Amin Izadpanah, et al.
Published: (2022-08-01) -
TRAF3IP3 promotes glioma progression through the ERK signaling pathway
by: Qi Lin, et al.
Published: (2022-09-01) -
TRAF3IP3 Is Cleaved by EV71 3C Protease and Exhibits Antiviral Activity
by: Hui Li, et al.
Published: (2022-06-01) -
EXPRESSION OF TH17-LYMPHOCYTE ADAPTER – TRAF3IP2 IN THE SKIN OF PSORIASIS PATIENTS
by: V. R. Khairutdinov, et al.
Published: (2014-07-01)